Novel approaches to flavivirus drug discovery
- 22 March 2012
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Drug Discovery
- Vol. 7 (5), 417-428
- https://doi.org/10.1517/17460441.2012.673579
Abstract
Introduction: The members of the family Flaviviridae, including West Nile virus, yellow fever virus and dengue virus, are important human pathogens that are expanding their impact around the globe. The four serotypes of dengue infect 50 – 100 million people each year, yet the only clinical treatment is supportive care to reduce symptoms. Drugs that employ novel inhibition mechanisms and targets are urgently needed to combat the growing incidence of dengue worldwide. Areas covered: The authors discuss recently discovered flavivirus inhibitors with a focus on antivirals targeting non-enzymatic proteins of the dengue virus lifecycle. Specifically, the authors discuss the flaviviruses, the need for novel inhibitors and the criteria for successful antiviral drug development. Current literature describing new advances in antiviral therapy at each stage of the flavivirus lifecycle (entry, endosomal escape, viral RNA processing and replication, assembly and immune evasion) are evaluated and summarized. Expert opinion: Overall, the prognosis of flavivirus antiviral drug development is positive: new effective compounds have been discovered and studied. However, repurposing existing compounds and a greater translation to the clinical setting are recommended in order to combat the growing threat of flaviviruses.Keywords
This publication has 86 references indexed in Scilit:
- Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse modelAntiviral Research, 2011
- Self-Assembling Peptide Nanotubes with Antiviral Activity against Hepatitis C VirusCell Chemical Biology, 2011
- N-linked glycosylation of dengue virus NS1 protein modulates secretion, cell-surface expression, hexamer stability, and interactions with human complementVirology, 2011
- Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesisProceedings of the National Academy of Sciences, 2010
- Antiviral Compounds Discovered by Virtual Screening of Small−Molecule Libraries against Dengue Virus E ProteinACS Chemical Biology, 2008
- Design, Synthesis, and Biological Evaluation of Antiviral Agents Targeting Flavivirus Envelope ProteinsJournal of Medicinal Chemistry, 2008
- Closing the door on flaviviruses: Entry as a target for antiviral drug designAntiviral Research, 2008
- Flavivirus methyltransferase: A novel antiviral targetAntiviral Research, 2008
- West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor HProceedings of the National Academy of Sciences, 2006
- A structural perspective of the flavivirus life cycleNature Reviews Microbiology, 2005